Institute for Advanced Discovery & Innovation

Institute Faculty


Richard Berman

Richard Berman is director of the Patel College of Global Sustainability, visiting social entrepreneurship professor in the Muma College of Business, and a professor in the institute. A recognized global leader in health care education and management, he has consulted for the Commissioner of the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, McKinsey & Company, and the government of Rwanda. He has served as New York State Commissioner of Housing and Economic Development and trustee of the State University of New York, as well as on the Commission on Advancement of Racial and Ethnic Equality of the American Council on Education, the Division III President's Council of NCAA, ProPAC, and the New York State's Commissioner's Advisory Council on Higher Education. He was advisor to the Joint Special Representative of the African Union—United Nations Mission in Darfur (UNAMID)—the then-largest peacekeeping operation in the world. He was Manhattanville College's tenth President and is credited with turning the struggling college into a high-ranking liberal arts college. Previously, he was the executive vice president of NYU Medical Center and professor of health care management at the NYU School of Medicine. He is a member of the NAM and on the boards of EmblemHealth, Seeds of Peace, and the Savannah Centre for Diplomacy, Democracy and Development in Abuja, Nigeria. He received his BBA, MBA, and MPH from the University of Michigan in Ann Arbor and holds honorary doctorates from Manhattanville College and New York Medical College.

Dr. Robert H. Byrne

Robert H. Byrne is a Distinguished University Professor in the College of Marine Science at USF. He holds a BS degree in physics from the University of Chicago, an MS in physics from DePaul University, an MA in chemistry from Boston University, and a PhD in oceanography from the University of Rhode Island. He has made important contributions in the field of marine physical chemistry — specifically, investigating the speciation of trace metals in seawater, developing new procedures for characterizing the carbon dioxide (CO2) system in aqueous environments, and designing new instrumentation for measuring nutrients, trace elements, and CO2 system constituents in freshwater and seawater. His field research has included more than 560 days at sea in the Gulf of Mexico and the Atlantic, Pacific, Indian, and Arctic Oceans. He holds fourteen U.S. and international patents and is one of the co-founders of Ocean Optics, Inc. He has written 200 peer-reviewed publications, serving as first or second author on two-thirds of these. He has also served as a reviewer and editor for various agencies and academic journals, including more than two decades as an associate editor for the journal Geochemica et Cosmochimica Acta. He is a fellow of the American Geophysical Union, the AAAS, and the NAI.

William Cavanaugh III

William Cavanaugh III is a professor in the institute and was the chairman and CEO of Progress Energy until his retirement in 2004. After completing his BS in mechanical engineering at Tulane University in 1961, he joined the U.S. Navy and became a nuclear submarine officer. Upon his honorable discharge, he began his long and productive career in the utility industry, holding key executive positions at Arkansas Power & Light, Louisiana Power & Light, and Mississippi Power & Light. His success in guiding these companies led to his taking over Carolina Power & Light, where he served as president and COO and later as CEO and chairman, leading the company to financial success and new levels of efficiency in its operations and power generation. In 2000, he negotiated the purchase of Florida Progress Corporation, merging it with CP&L to become Progress Energy, a Fortune 500 energy company serving over three million customers. After his retirement from Progress Energy, he became chairman of the World Association for Nuclear Operations (WANO), where he oversaw the institution of a mandatory peer review process for member organizations, among other initiatives. He was elected as a member of the NAE in 2001 for "contributions to excellence in the generation of electricity from nuclear power by establishing and achieving exemplary levels of performance." He has received the William S. Lee Award for Industry Leadership from the Nuclear Energy Institute and the Walter H. Zinn Award from the American Nuclear Society.

Selim Chacour

Selim Chacour is a professor in the institute and was the principal founder of American Hydro Corporation, which, under his leadership, became an industry leader in hydro turbine upgrades. In his industry, he is hailed for various improvements to the design of turbine components and for completely revolutionizing runner design by creating computer design programs which obviated the need for physical model testing, the previous standard. This work had a great impact on hydro plants already in existence, allowing them to upgrade their facilities and improve performance. His turbine runner designs have been used in such iconic structures as the Aswan High Dam in Egypt and the Hoover Dam in the United States. Additionally, his designs have generated concrete improvements in efficiency, resulting in gains in power generation and reductions in costs and environmental impact. Lauded as a visionary, he was elected as a member of the NAE "for pioneering three-dimensional finite element computations in mechanical and hydraulic design, leadership in hydro turbine research and development, and business stewardship," highlighting his status as an innovator and as a business leader. He is also the recipient of the National Hydropower Association's Henwood Award, the industry's highest honor, and holds eight U.S. patents for his work. In 2015, he became a fellow of the NAI.

David M. Eddy

David M. Eddy is a professor in the institute and a physician, mathematician, and health care analyst who has done seminal work in mathematical modeling of diseases, clinical practice guidelines, and evidence-based medicine. In summarizing his career, the NAM (of which he is a member) emphasized his innovative thinking and practices, noting that "more than 25 years ago, Eddy wrote the seminal paper on the role of guidelines in medical decision-making, the first Markov model applied to clinical problems, and the original criteria for coverage decisions; he was the first to use and publish the term 'evidence-based'." He was a professor at Stanford University and the J. Alexander McMahon Professor at Duke University before he left academia to become an independent researcher and entrepreneur. He founded Archimedes Inc., a health care modeling company, and was chief medical officer until he retired in 2013. The author of five books and more than 100 first-authored papers, including a series of 28 in the Journal of the American Medical Association, his writings span from technical mathematical theories to broad health policy topics. He has received 10 national and international awards in several fields, including applied mathematics, health technology assessment, health care quality, environmental sciences, and outcomes research, as well as awards from five organizations for lifetime achievement. In 2012, he was ranked the 13th most innovative person in health care by "Health Future 100." In 2015, he became a fellow of the NAI. He holds two U.S. patents.

Michael W. Fountain

Michael W. Fountain serves as the founding director of USF's Center for Entrepreneurship, which has been ranked by Princeton Review and Entrepreneur Magazine as one of the top 25 entrepreneurship educational programs in the United States for the past nine years. He serves both as a professor in industrial and management systems engineering, psychiatry and behavioral medicine, and pharmacy and as the John and Beverley Grant Endowed Chair in Entrepreneurship in the Muma College of Business. Holding more than 60 U.S. and foreign patents, which are used in over 150 healthcare and consumer products worldwide, he is a fellow of the NAI and a founding member of its USF chapter. He has focused the past 30 years on creating, financing, growing, and harvesting biotechnology, medical device, and life sciences companies. He has founded or co-founded 12 new ventures, three of which became publicly traded companies. He has served in a variety of corporate leadership roles, including chief scientific officer, chief executive officer, and chairman of the board. He is the author of numerous peer reviewed articles on micro- and nano-drug delivery systems and entrepreneurship theory and practice. He received his Honors BS from Samford University, his MS and PhD from Auburn University, and his MBA from Bristol University.

Richard D. Gitlin

Richard D. Gitlin is a State of Florida 21st Century World Class Scholar, Distinguished University Professor, and the Agere Systems Chair of Electrical Engineering at the University of South Florida. He has more than 45 years of leadership in the communications industry and in academia, and he has a record of significant research contributions that have been sustained and prolific over several decades. His research focuses on the intersection of communications with medicine, especially in vivo wireless communications and networking that is used to advance minimally invasive surgery and other cyber-physical health care systems. Before joining the faculty at USF, Gitlin was at Bell Labs/Lucent Technologies, where he was the co-inventor of Digital Subscriber Line (DSL), and at his retirement, he was senior VP for communications and networking research. He is a member of the NAE, Fellow of the IEEE, Bell Laboratories Fellow, Charter Fellow of the NAI, and co-recipient of the Thomas Alva Edison Patent Award and the S.O. Rice Prize. He has co-authored a text, published 100 papers, and holds 55 U.S. patents. He is currently working on MARVEL, a robotic imaging system used to aid minimally invasive surgery, and is partnering with Jabil to develop sensors that can collect and wirelessly transmit potentially life-saving physiological data.

D. Yogi Goswami

D. Yogi Goswami is Distinguished University Professor, John and Naida Ramil Professor of Chemical Engineering, and director of the Clean Energy Research Center at the University of South Florida. His research focuses on solar energy fundamentals and applications, energy storage, thermodynamics, indoor air quality (IAQ), HVAC, hydrogen, and fuel cells. He is editor-in-chief of Solar Energy and Progress in Solar Energy and author/editor of 18 books, 16 book chapters, six conference proceedings, and over 350 refereed papers. He also holds 18 U.S. patents. He is an NAI Charter Fellow, a fellow of ASME International, ASHRAE, and ASES, and a member of the Pan American Academy of Engineering. He has received the ISES' Farrington Daniels Award, ASME's Frank Kreith Energy medal, ASME's John Yellott Award for Solar Energy, and the ASES' Charles Greely Abbott award. He is a 2016 inductee of the Florida Inventors Hall of Fame.

Stephen B. Liggett

Stephen B. Liggett is associate vice president of USF Health, vice dean for research in the Morsani College of Medicine, and professor of internal medicine and molecular pharmacology and physiology at the University of South Florida. He discovered and characterized receptor polymorphisms. He was the first to discover polymorphisms of the G-protein coupled receptor superfamily, to which more than 50% of all drugs are targeted. This discovery moved the field of pharmacogenomics from one that concentrated on metabolizing enzymes to one that includes target proteins for determining drug responsiveness. He also developed biotechnical companies related to personalized medicine based on these discoveries. His fundamental studies in humans and genetically altered mice have led to new advances in the areas of heart failure, hypertension, and obstructive lung diseases. He holds 16 U.S. patents and has more than 235 publications. He is a fellow of the American College of Chest Physicians and the National Academy of Inventors, as well as the recipient of the Frontiers in Pharmacology Award from Case Western Reserve University and Excellence in Science Award from Thomas Jefferson University.

Charles J. Lockwood

Charles J. Lockwood, senior vice president of USF Health and dean of the Morsani College of Medicine at USF, is internationally known for research expertise in uterine hemostasis and preterm birth. Previously, he was dean of The Ohio State University College of Medicine; Anita O'Keeffe Young Professor and chair of obstetrics and gynecology at the Yale School of Medicine; and chair of obstetrics and gynecology at the NYU School of Medicine and interim director of their NCI-designated Cancer Center. He graduated from Brown University, received his MD from the University of Pennsylvania, served a residency at Pennsylvania Hospital and a Maternal-Fetal Medicine fellowship at Yale. He also holds a master's in health care management from Harvard. He has garnered multiple NIH and March of Dimes grants and published over 280 peer reviewed papers (h-index of 66). He has co-edited five obstetrical textbooks, three with multiple editions; serves on multiple editorial boards; and is editor-in-chief of Contemporary OB/GYN, where his editorials have garnered five national awards. He has served on multiple NIH study sections, chaired FDA and American College of Obstetricians and Gynecologists committees, is secretary of the American Gynecological and Obstetrical Society, and sits on the National Board of the March of Dimes Foundation. He is a member of the Sigma Xi and Alpha Omega Alpha honor societies, former president of the Society for Reproductive Investigation and winner of its Pardi Distinguished Scientist Award, and a member of the NAM. He maintains an active research lab at USF.

Dean F. Martin

Dean F. Martin is Distinguished University Professor Emeritus at USF, where he has been a member of the faculty since 1964. Previously, he was a member of the faculty of the University of Illinois as instructor and assistant professor of inorganic chemistry. He and his wife, Barbara B. Martin, share research interests concerned with the coordination chemistry of natural water systems, including problems of red tide and aquatic weeds. The Martins were editors of the Florida Scientist from 1984-2010. He is the author or co-author of over 450 publications, including six books. He received his BA from Grinnell College and his PhD from the Pennsylvania State University. In 1958-59, he was a National Science Foundation postdoctoral fellow at University College London. He later received a Career Development Award from the Division of General Medical Sciences, NIH, to study the chemistry and chemical environment of algal toxins. In 1970-71, he was a visiting professor of physiology and pharmacology at Duke University Medical Center. He is the recipient of the Florida Award, the Civic Service Award of the Florida Section, and the F. J. Zimmermann Award in Environmental Science from the Central Wisconsin Section, sponsored by Zimpro Inc. He is also a fellow of the AAAS and the NAI. Dean and Barbara Martin were the co-recipients of the 1994 Medalist Award of the Florida Academy of Sciences, its highest award. He has been active in the American Chemical Society, and he has held several positions in the Aquatic Plant Management Society.

Shyam Mohapara

Shyam S. Mohapatra is Distinguished USF Health Professor, director of the Division of Translational Medicine at the University of South Florida, and a research career scientist at the James A. Haley VA Hospital in Tampa. He also directs the USF Center for Research and Education in Nanobioengineering. He is recognized for his many inventions in the field of nanoscale biomedical diagnostics and therapeutics in cancers, asthma, viral infections, and traumatic brain injury. His inventions and co-inventions have led to several customized cell-targeted nanoparticles with diverse drug payloads, a nano-HIV detection kit, and, most recently, to a nanoscale platform for anti-cancer drug discovery and personalized cancer treatment. He also serves as associate dean of graduate programs at the USF College of Pharmacy and established a highly innovative online Master of Science program in pharmaceutical nanotechnology. His research has brought USF over $20 million in extramural funds, and he has published over 165 papers and holds over 30 U.S. and foreign patents. His research has spawned inventions that have spun out companies. He co-founded Transgenex Nanobiotech Inc, a USF spin-out company, which focuses on commercializing nanoscale innovations. He is a Charter Fellow of the NAI, a fellow of the American Academy of Allergy, Asthma & Immunology, and a 2014 inductee of the Florida Inventors Hall of Fame.

Victor L. Poirier

Victor Poirier is a professor in the institute and former CEO and president of Thermo Cardiosystems and chief technology advisor of Thoratec Corp. He is internationally recognized as a pioneer for the design, development, clinical trial, and commercialization of first-generation left-ventricular assist systems for treating heart failure. He is a founding fellow of the American Institute for Medical and Biological Engineering and the International Academy of Artificial Organ Pioneers of ICMT, a fellow of the National Academy of Inventors, and a member of the NAE. He is the recipient of the Mediterranean Institute of Cardiology Award (France), the Himet Award, and the Barney Clark Award from the American Society for Artificial Internal Organs and was elected by his peers as the national "Engineer of the Year" (Design News, 1992), among other honors and awards. He holds 17 U.S. patents and has published over 110 papers. He is currently exploring ways to teach innovation and innovative thinking practices.

Paul R. Sanberg

Paul R. Sanberg is senior vice president for research, innovation and economic development, Distinguished University Professor of neuroscience, biomedical engineering, and business at the University of South Florida, and founder and president of the NAI. He is an inventor on 111 U.S. and foreign patents and has worked as an executive with a number of startup companies involved in cell therapy for degenerative disorders. His work has been instrumental in translating novel pharmaceutical and cellular therapeutics to clinical trials for Tourette syndrome, depression, stroke, Huntington's disease, Parkinson's disease, ALS, and Alzheimer's disease. He is the 2015 Medalist of the Florida Academy of Sciences; a 2015 inductee of the Florida Inventors Hall of Fame; fellow of the AAAS, American Institute for Medical and Biological Engineering, and Royal Societies of Chemistry, Public Health, and Medicine; Charter Fellow of the NAI; and AAAS-Lemelson Invention Ambassador. He serves on the nomination evaluation committee of the United States National Medal of Technology and Innovation with the U.S. Department of Commerce, Smithsonian Innovation Festival selection committee, and advisory board of the APLU Commission on Innovation, Competitiveness, and Economic Prosperity. He has published more than 600 scientific articles and 14 books.

Lyle H. Schwartz

Lyle H. Schwartz is a professor in the institute and retired director, Air Force Office of Scientific Research. He was formerly professor of materials science and engineering at Northwestern University for 20 years and director of Northwestern's Materials Research Center for five of those years. He then became director of the Materials Science and Engineering Laboratory at the National Institute of Standards and Technology (NIST), where he served for more than 12 years. After NIST, he moved to the Air Force Office of Scientific Research, where, as director, he had responsibility for the entire basic research program of the Air Force. He has played a significant role in shaping government policies on many materials issues. He was elected as a member of the NAE for "leadership in materials research and in coordinating industry and government collaboration in materials engineering." He is a recipient of the Presidential rank of Meritorious Executive of the government's Senior Executive Service, the Gold Medal Award of the Department of Commerce, the National Materials Advancement Award of the Federation of Materials Societies, and the Leadership Award of the Minerals, Metals, and Materials Society. His current interests include government policy for R&D, particularly for materials R&D, materials science education (STEM) at K-12 levels, and enhanced public understanding of the roles and importance of technology in society. He is bringing his interests in K-12 education to bear in the Tampa area as part of his commitment to USF and the Institute.

James J. Wynne

James Wynne is a professor in the institute and a senior member of the staff of IBM Research Headquarters. He manages the T. J. Watson Research Center's outreach to local schools and coordinates IBM's global participation in DiscoverE, serving as a catalyst to marshal the resources of IBM to enhance the Science, Technology, Engineering and Mathematics (STEM) education of K-12 students. His research contributions have been in nonlinear optics of semiconductors and insulators, nonlinear spectroscopy of atomic and molecular vapors, laser etching and fluorescence studies of human and animal tissue, and cluster science. He and two IBM colleagues discovered excimer laser surgery in 1981, laying the foundation for LASIK and PRK, techniques for surgically correcting myopia, astigmatism, and hyperopia. For this discovery, he has received many awards, including induction into the NIHF, the National Medal of Technology and Innovation, and the Russ Prize of the National Academy of Engineering (NAE). He is a member of the NAE, fellow of the NAI, member of the USF Chapter of the NAI, and a research collaborator with USF faculty. He holds 12 U.S. patents. His current research encompasses the development of novel applications of the excimer laser, especially its use as a "smart scalpel" for removing necrotic lesions of the skin while minimizing collateral damage to underlying and adjacent viable tissue.